About Glooko
Glooko is a diabetes management platform that aggregates data from glucose meters, CGMs, and insulin pumps to provide AI-driven insights for patients and clinicians.
Mission & Story
Mission
We're transforming diabetes across the full continuum of care.
Clinical Focus
Medical conditions and clinical areas addressed by Glooko.
Who It Serves
Milestones & Awards
Recent Milestones
Acquired Monarch Medical Technologies to expand into inpatient glycemic management; Won Best Overall MedTech Software in 2026 MedTech Breakthrough Awards; Integrated with Roche Accu-Chek SmartGuide CGM in select European countries; Launched refreshed Glooko Mobile App; Released new clinic dashboard for population health management
Awards & Recognition
Best Overall MedTech Software - 2026 MedTech Breakthrough Awards
Key Partnerships
Social & Media
Follow on
Latest Updates
Glooko Web 26.2 and Mobile 6.16 Release Brings Pump Settings Into the EHR and Adds Smarter Patient Context
EHR Integration: The New Standard for Diabetes Care Insights and Management
The ROI of EHR-Integrated Diabetes Data
Advancing Connected Diabetes Management with mylife Diabetes Care
The Expanding Need for Effective Diabetes Care Delivery Models
Company Details
- Founded
- 2010
- Headquarters
- Palo Alto, CA, USA
- Employees
- 300
- Stage
- growth
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 46 →
Abbott Diabetes Care
Abbott Diabetes Care develops FreeStyle Libre, a world-leading continuous glucose monitoring (CGM) portfolio for diabetes management with advanced analytics and innovation.
Amalgam Rx
Amalgam Rx develops AI-powered digital therapeutics and Software as a Medical Device (SaMD) solutions for chronic disease management. The company partners with life sciences companies, health plans, and providers to deliver regulated digital health applications and EHR-integrated clinical decision support tools.
Arkray
ARKRAY USA manufactures and distributes blood glucose monitoring systems, clinical diagnostic equipment, and oral wellness products. The company serves consumers with diabetes, healthcare professionals, and clinical laboratories with accurate, affordable diagnostic solutions.
BeatO
BeatO is a digital health platform specializing in diabetes management and weight loss solutions. The company offers smart glucose monitoring devices, GLP-1 weight loss programs, and a comprehensive diabetes care program combining connected devices, doctor consultations, and health coaching for over 2 million patients across India.
Brook Health
AI-powered remote patient monitoring and chronic disease management platform for conditions like diabetes, hypertension, and heart disease.
Cadence
Cadence delivers AI-powered remote patient care programs for chronic disease management. The company partners with health systems, payers, and medical groups to provide 24/7 monitoring, medication management, and clinical support for patients with hypertension, heart failure, diabetes, and other chronic conditions.
Cala Health
Cala Health develops the Cala kIQ System, an FDA-cleared wearable device that delivers non-invasive neuromodulation therapy for action hand tremor. The device uses transcutaneous afferent patterned stimulation (TAPS) to provide on-demand tremor relief for people with essential tremor and Parkinson's disease.
Calibrate
Calibrate is a metabolic health company that combines clinician-prescribed GLP-1 medications with 1:1 video coaching and science-backed curriculum to help members achieve sustainable weight loss. Members lose an average of 19% of their body weight achieved over three years.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.